title: Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
abstract: Recent studies have shown that transvenous atrial cardioversion is feasible with lead configurations primarily designed for implantable cardioverter defibrillators (ICD). The purpose of this study was to examine the influence of an active pectoral ICD can on the atrial cardioversion threshold (ADFT). Forty consecutive patients received a transvenous single lead system (Endotak DSP 0125, CPI, St. Paul, MN, USA) in combination with a left subpectoral ICD (Ventak Mini, CPI) for treatment of malignant ventricular tachyarrhythmias. Patients were randomized into two groups: 21 received a Hot Can 1743 and 19 patients a Cold Can 1741. Step-down testing of the ventricular defibrillation threshold (VDFT) was performed intraoperatively and evaluation of the ADFT for induced atrial fibrillation (AF) at predischarge. After testing, each patient received a 2-J shock and was asked to quantify discomfort on a numerical scale ranging from 0 to 10. Both groups were comparable with regard to all clinical parameters studied. The mean VDFT in patients with a Hot Can device was significantly lower than in patients with a Cold Can (7.5 +/- 2.3 J vs 9.8 +/- 3.8 J; P < 0.03). The mean ADFT in the Hot Can group tended to be lower than in the group with Cold Cans (3.4 +/- 1.4 J vs 4.5 +/- 2.4 J; P = 0.07), and the proportion of patients in whom atrial cardioversion was accomplished at low energies (< or = 3 J) was higher in patients with active compared with patients with inactive pulse generators (57% vs 26%; P < 0.04). The mean discomfort reported after delivery of a 2-J shock was comparable in both groups (Hot Can 5.2 +/- 1.9; Cold Can: 5.3 +/- 2.1; P = NS). We conclude that the inclusion of an active left subpectoral can in the defibrillation vector of a ventricular ICD seems to reduce the energy requirements for atrial cardioversion without increasing the discomfort caused by low energy shocks.
authors.affiliation: Abteilung für Thorax- und Herz-Gefäss-Chirurgie, Universitätskliniken des Saarlandes, Homburg/Saar, Germany. heisel@med-in.uni-sb.de
authors.forename: A
authors.initials: A
authors.lastname: Heisel
authors.forename: J
authors.initials: J
authors.lastname: Jung
authors.forename: N
authors.initials: N
authors.lastname: Nikoloudakis
authors.forename: R
authors.initials: R
authors.lastname: Fries
authors.forename: H J
authors.initials: HJ
authors.lastname: Schäfers
authors.forename: H
authors.initials: H
authors.lastname: Schieffer
mesh_terms: D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D002405:Catheterization, Central Venous / Q000379:methods*; D002908:Chronic Disease; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation*; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome; D014683:Vena Cava, Superior